Join a High-Impact 2-Day Programme
Engage with leading drug development and delivery leaders in a dynamic, expert-led environment. This conference brings together forward-thinking innovators to explore cutting-edge case studies, breakthrough vaccine and therapeutic applications, and the evolving capabilities of transdermal and microneedle technologies.
Transdermal and microneedle patches are hold opportunity to 'go beyond the needle' and revolutionise pharmaceutical development, offering enhanced accessibility, and long-term delivery solutions. With applications ranging from improved vaccine distribution to advanced diagnostics, these technologies are able to reshape healthcare by increasing efficacy and expanding global access to life-changing treatments.
Key Topics & Discussions:
- Breakthroughs in Clinical Data & Vaccine Delivery - Examining real-world success stories and research-backed evidence.
- Innovative Capabilities & Applications - Exploring how transdermal and microneedle patches are unlocking new therapeutic possibilities.
- Manufacturing Challenges & Progress - Addressing scalability, regulatory compliance, and formulation advancements.
- Regulatory Insights & Expert Q&A - Engaging with key regulators and industry leaders to navigate development, approval pathways and market adoption.
2025 Speakers
- Ajoy Chakrabarti, Portfolio & Platform Lead, Polio, Bill & Melinda Gates Foundation (Subject to Final Confirmation)
- Amir Reichman, CEO, Scinai Immunotherapeutics Ltd.
- Arabe Ahmed, Medicinal Technical Specialist, BSI
- Brian Pfister, Vice President, Gylden Pharma
- Conor O Mahony, Principal Researcher, Tyndall National Institute
- James Birchall, Deputy Head, School of Pharmacy and Pharmaceutical Sciences, College of Biomedical and Life Sciences, Cardiff University
- John Burt, CEO, Medherant
- Mateusz Hasso-Agopsowicz, Technical Officer, World Health Organization
- Muhammet Avcil, Managing Director, Imperial BioScience
- Renske Hesselink, ,Director MSC Innovations Coalition for Epidemic Preparedness Innovations (CEPI)
- Sanjiv Sharma, Senior Lecturer in Infectious Diseases and Antimicrobial Resistance, University of Liverpool
- Senior Representative, Vaxxas
- Steve Damon, CEO, Micron Biomedical
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Hilton London Kensington
179-199 Holland Park Ave, Kensington, W11 4UL
London, UK
